Health
Sabari Stresses the Importance of Molecular Testing in Lung Cancer – OncLive
Joshua K. Sabari, MD, discussed the management of patients with early-stage and metastatic lung cancer, the roles of molecular testing, surgery, staging, and ongoing…
Concurrent tissue- and plasma-based testing is needed in all patients to understand tumor heterogeneity, identify potential de novo resistance mutations, and ensure that existing mutations are not missed by potentially false negative results of liquid biopsy, according to Joshua K. Sabari, MD.
Despite all of our advances in lung cancer, unfortunately this disease is often incurable, explained Sabari. Even in the era of immunotherapy, it is critically important to not forget molecular testing. PD-L1…
-
Business20 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General21 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
General20 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts
-
Noosa News12 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up